Charles River Laboratories International, Inc. News Headlines

CRL 
$53.31
*  
0.13
0.24%
Get CRL Alerts
*Delayed - data as of Jul. 9, 2014  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    CRL Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Priority Review for Bayer's Riociguat - Analyst Blog
4/9/2013 4:08:46 PM - Zacks.com

Data Presented on Bayer's ATX-101 - Analyst Blog
4/8/2013 6:10:38 PM - Zacks.com

Glaxo's Flu Vaccine Approved - Analyst Blog
4/8/2013 5:00:01 PM - Zacks.com

Glaxo's Influenza Vaccine Gets CRL - Analyst Blog
4/1/2013 6:50:01 PM - Zacks.com

Japanese Approval for Bayer's drug - Analyst Blog
3/27/2013 2:25:40 PM - Zacks.com

Another CRL for UTHR's Oral Remodulin - Analyst Blog
3/26/2013 4:26:37 PM - Zacks.com

CHMP Positive on Bayer's Xarelto - Analyst Blog
3/25/2013 5:28:43 PM - Zacks.com

Good News for Novartis Candidate - Analyst Blog
3/19/2013 3:46:58 PM - Zacks.com

Loss at OREX Narrower than Expected - Analyst Blog
3/14/2013 5:45:16 PM - Zacks.com

Bayer/JNJ's Xarelto in New Studies - Analyst Blog
3/12/2013 4:10:31 PM - Zacks.com

Positive News for Novartis - Analyst Blog
3/6/2013 6:40:01 PM - Zacks.com

Setback for Bayer/JNJ's Xarelto - Analyst Blog
3/5/2013 7:20:01 PM - Zacks.com

Regeneron to Earn More Royalty - Analyst Blog
3/5/2013 2:40:01 PM - Zacks.com

Loss at Dynavax Wider than Expected - Analyst Blog
3/5/2013 2:17:01 PM - Zacks.com

Salix Misses on Both Counts - Analyst Blog
3/5/2013 10:00:01 AM - Zacks.com

Encouraging News at Chelsea - Analyst Blog
2/21/2013 5:30:01 PM - Zacks.com

Launch at Novo Nordisk - Analyst Blog
2/20/2013 5:00:01 PM - Zacks.com

March Action Date for UTHR Candidate - Analyst Blog
2/20/2013 1:10:01 PM - Zacks.com

Mixed 4Q for Charles River - Analyst Blog
2/14/2013 4:27:01 PM - Zacks.com

Robert Olstein's Largest New Stock Picks
2/12/2013 4:44:43 PM - GuruFocus

Novo Nordisk Suffers Setback - Analyst Blog
2/11/2013 5:45:18 PM - Zacks.com

Westport Funds Buys 2 New Holdings, Both Surge
2/6/2013 5:44:19 PM - GuruFocus

CRL for Impax' Rytary - Analyst Blog
1/23/2013 5:30:01 PM - Zacks.com

Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE
1/13/2013 7:13:28 PM - GuruFocus

Update on Orexigen's Contrave - Analyst Blog
1/10/2013 6:51:01 PM - Zacks.com